BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3801968)

  • 1. Altered regulation of c-myc expression in adenovirus-transformed cells.
    Braithwaite AW; Fry KE; LeJeune S; Naora H
    Can J Genet Cytol; 1986 Oct; 28(5):712-24. PubMed ID: 3801968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation.
    Campisi J; Gray HE; Pardee AB; Dean M; Sonenshein GE
    Cell; 1984 Feb; 36(2):241-7. PubMed ID: 6692471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of glucose transporter, c-myc, and transin RNA levels by Ha-rasT24 is independent of its effect on the cell cycle.
    Godwin AK; Lieberman MW
    Mol Carcinog; 1991; 4(4):275-85. PubMed ID: 1872950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of c-myc oncogene mRNA are invariant throughout the cell cycle.
    Thompson CB; Challoner PB; Neiman PE; Groudine M
    Nature; 1985 Mar 28-Apr 3; 314(6009):363-6. PubMed ID: 3982504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in c-fos and c-myc mRNA levels in untransformed and SV40-transformed 3Y1 fibroblasts after addition of serum: its relationship to the control of initiation of S phase.
    Okuda A; Matsuzaki A; Kimura G
    Exp Cell Res; 1989 Nov; 185(1):258-70. PubMed ID: 2553463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth-dependent synthesis of c-myc-encoded proteins: early stimulation by serum factors in synchronized mouse 3T3 cells.
    Persson H; Gray HE; Godeau F
    Mol Cell Biol; 1985 Nov; 5(11):2903-12. PubMed ID: 3915769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle dependent growth factor regulation of gene expression.
    Morgan CJ; Pledger WJ
    J Cell Physiol; 1989 Dec; 141(3):535-42. PubMed ID: 2512304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-myc gene is transcribed at high rate in G0-arrested fibroblasts and is post-transcriptionally regulated in response to growth factors.
    Blanchard JM; Piechaczyk M; Dani C; Chambard JC; Franchi A; Pouyssegur J; Jeanteur P
    Nature; 1985 Oct 3-9; 317(6036):443-5. PubMed ID: 3900742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-myc mRNA levels in the cell cycle change in mouse erythroleukemia cells following inducer treatment.
    Lachman HM; Hatton KS; Skoultchi AI; Schildkraut CL
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5323-7. PubMed ID: 3860863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cell cycle duration by c-myc levels.
    Karn J; Watson JV; Lowe AD; Green SM; Vedeckis W
    Oncogene; 1989 Jun; 4(6):773-87. PubMed ID: 2660073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced expression and state of the c-myc oncogene in chemically and X-ray-transformed C3H/10T1/2 Cl 8 mouse embryo fibroblasts.
    Billings PC; Shuin T; Lillehaug J; Miura T; Roy-Burman P; Landolph JR
    Cancer Res; 1987 Jul; 47(14):3643-9. PubMed ID: 2439194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged inhibition by X-rays of DNA synthesis in cells obtained by transformation of primary rat embryo fibroblasts with oncogenes H-ras and v-myc.
    Wang Y; Iliakis G
    Cancer Res; 1992 Feb; 52(3):508-14. PubMed ID: 1732037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of c-myc expression correlated with E1a expression but not with the transformed phenotype.
    Dion PA; Fleurent J; Roberge D; Weber JM
    Virus Res; 1992 Dec; 26(3):231-40. PubMed ID: 1492496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
    Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
    Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
    Dolnikov A; Millington M; Sun LQ; Symonds G
    Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cellular density and viral oncogenes on the major histocompatibility complex class I antigen response to gamma-interferon in BALB-c/3T3 cells.
    Offermann MK; Faller DV
    Cancer Res; 1990 Feb; 50(3):601-5. PubMed ID: 2105158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
    Chen HW; Huang HC
    Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activities of v-myc and rearranged c-myc oncogenes in rat fibroblast cells in culture.
    Mougneau E; Lemieux L; Rassoulzadegan M; Cuzin F
    Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5758-62. PubMed ID: 6091107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential influence of adjacent normal cells on the proliferation of mammalian cells transformed by the viral oncogenes myc, ras and src.
    Bignami M; Rosa S; La Rocca SA; Falcone G; Tatò F
    Oncogene; 1988 May; 2(5):509-14. PubMed ID: 3287279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.